長安汽車朱華榮:“缺芯貴電”致長安損失60.6萬輛產量 建議優化上遊原材料資源配置
格隆匯11月9日丨長安汽車董事長朱華榮今日在2022中國汽車論壇上表示,“缺芯貴電”問題對汽車產業的生產秩序造成嚴重破壞,1-9月份長安汽車損失60.6萬輛產量,“缺芯”造成大量半成品庫存,“貴電”導致單車成本增加5000-35000元。針對“缺芯”問題,朱華榮建議加快芯片行業通用化的進程,推動供應鏈的透明化,芯片商tier1要建立新型的供應商關係,建立與汽車行業的直通直聯的模式;針對“貴電”問題,朱華榮建議國家層面打擊個別企業原材料囤貨與炒作的行爲、加強政策引導,優化上遊原材料資源配置,行業層面推動廢舊電池及關鍵金屬資源回收利用,完善動力電池回收利用管理體系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.